New clot-sucking device tested in real-world vein clot treatment

NCT ID NCT07708376

Not yet recruiting Disease control Sponsor: FlowPhysix, Inc. Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tracks how well the FLOWRUNNER Aspiration System removes symptomatic blood clots from veins in the arms or legs during routine care. About 218 adults with deep-vein clots will be followed to see if the device safely restores blood flow and reduces clot-related disability. The goal is to measure real-world effectiveness and safety outside of a controlled trial setting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: a mechanical thrombectomy device called the FLOWRUNNER Aspiration System, which suctions out blood clots
What this could lead to: If successful, this registry could confirm that the FLOWRUNNER system is a safe and effective tool for removing symptomatic venous clots in routine care.
What could go wrong: This is an observational registry, not a randomized trial, so results may be influenced by patient selection and lack a control group. The device may still carry risks like bleeding or vessel damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VENOUS THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

thrombophilia due to thrombin defect thrombotic disease Venous Thrombosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

VENOUS THROMBOSIS VENOUS THROMBOSIS DEEP (LIMBS)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.